Home › NDC Lookup › RxCUI directory › RxCUI 1243034

Linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet — RxCUI 1243034

RxNorm drug concept · Semantic clinical drug
RxCUI 1243034 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1243034
Official nameLinagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslinagliptin 2.5 MG / metFORMIN HCl 850 MG Oral Tablet
FDA products mapped6
Package NDCs mapped12
Reported Medicaid activity (SDUD)45,645 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Linagliptin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Tradjenta helps your body manage blood sugar more effectively after meals. It works by protecting natural hormones in your gut — called incretins — that normally get destroyed too...
  • What exactly does Tradjenta do for my diabetes?
  • You take Tradjenta once a day — the exact time is less important than being consistent. The good news is that food doesn't really affect how well it works, so you can take it with...
  • Do I have to take it at a specific time of day, and does food matter?
📖 Read our full Linagliptin guide →

🕸️ Concept Web — How Linagliptin 2.5 MG / metformin hydrochloride 850... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet RxCUI 1243034

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Linagliptin 1100699
    • Metformin 6809
    • Linagliptin / metformin 1243019
    • Metformin hydrochloride 235743
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Jentadueto 1372706
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Linagliptin / metformin Oral Tablet 1243018
    • Linagliptin / metformin hydrochloride Oral Tablet 2647786
    • Linagliptin / metformin Oral Product 1243016
    • Linagliptin / metformin Pill 1243017
    • Linagliptin / metformin hydrochloride Oral Product 2661905
    • Linagliptin / metformin hydrochloride Pill 2659615
    • Linagliptin / metformin Oral Tablet [Jentadueto] 1243037
    • Linagliptin / metformin hydrochloride Oral Tablet [Jentadueto] 2654999
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Linagliptin 2.5 MG SCDC · 1243015
  • Metformin hydrochloride 850 MG SCDC · 861009
  • Linagliptin / metformin Oral Tablet SCDF · 1243018
  • Linagliptin / metformin hydrochloride Oral Tablet SCDFP · 2647786
  • Linagliptin / metformin Oral Product SCDG · 1243016
  • Linagliptin / metformin Pill SCDG · 1243017
  • Linagliptin / metformin hydrochloride Oral Product SCDGP · 2661905
  • Linagliptin / metformin hydrochloride Pill SCDGP · 2659615

Brand-Name Concepts

  • Linagliptin 2.5 MG / metformin hydrochloride 850 MG Oral Tablet [Jentadueto] SBD · 1243040
  • Linagliptin 2.5 MG / metformin hydrochloride 850 MG [Jentadueto] SBDC · 1243036
  • Linagliptin / metformin Oral Tablet [Jentadueto] SBDF · 1243037
  • Linagliptin / metformin hydrochloride Oral Tablet [Jentadueto] SBDFP · 2654999
  • Jentadueto Oral Product SBDG · 1243038
  • Jentadueto Pill SBDG · 1243039
  • Jentadueto BN · 1372706

📦 FDA Products & Package NDCs

6 products · 12 package NDCs
12 package NDCs map to RxCUI 1243034 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00597-0146-18 180 TABLET, FILM COATED in 1 BOTTLE (0597-0146-18) Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. 2012-02-13
00597-0146-60 60 TABLET, FILM COATED in 1 BOTTLE (0597-0146-60) Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. 2012-02-13
00597-0147-18 180 TABLET, FILM COATED in 1 BOTTLE (0597-0147-18) Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. 2012-02-13
00597-0147-60 60 TABLET, FILM COATED in 1 BOTTLE (0597-0147-60) Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. 2012-02-13
00597-0148-18 180 TABLET, FILM COATED in 1 BOTTLE (0597-0148-18) Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. 2012-02-13
00597-0148-60 60 TABLET, FILM COATED in 1 BOTTLE (0597-0148-60) Jentadueto Boehringer Ingelheim Pharmaceuticals, Inc. 2012-02-13
72205-0407-01 60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01) Linagliptin and metformin hydrochloride Novadoz Pharmaceuticals LLC 2025-11-04
72205-0407-02 180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02) Linagliptin and metformin hydrochloride Novadoz Pharmaceuticals LLC 2025-11-04
72205-0408-01 60 TABLET, FILM COATED in 1 BOTTLE (72205-408-01) Linagliptin and metformin hydrochloride Novadoz Pharmaceuticals LLC 2025-11-04
72205-0408-02 180 TABLET, FILM COATED in 1 BOTTLE (72205-408-02) Linagliptin and metformin hydrochloride Novadoz Pharmaceuticals LLC 2025-11-04
72205-0409-01 60 TABLET, FILM COATED in 1 BOTTLE (72205-409-01) Linagliptin and metformin hydrochloride Novadoz Pharmaceuticals LLC 2025-11-04
72205-0409-02 180 TABLET, FILM COATED in 1 BOTTLE (72205-409-02) Linagliptin and metformin hydrochloride Novadoz Pharmaceuticals LLC 2025-11-04
Observed labelers: Boehringer Ingelheim Pharmaceuticals, Inc. (6) · Novadoz Pharmaceuticals LLC (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.